Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Webb

Showing results (271-280 of 323) with videos related to

Pageof 33
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 28, 2020
Serial troponin measurements to monitor risk and response to endothelin A antagonism in chronic kidney diseaseAtul Anand, Tariq E Farrah, Eve Miller-Hodges, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 23, 2024
Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy)Kathleen M Scullion, Iain M MacIntyre, Sian Sloan-Dennison, et al.
American Journal of Physiology. Renal Physiology|July 19, 2013
An anatomically unbiased approach for analysis of renal BOLD magnetic resonance imagesRobert I Menzies, Andrew Zammit-Mangion, Lyam M Hollis, et al.
BMJ Open|August 9, 2015
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trialThomas M MacDonald, Bryan Williams, Mark Caulfield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2011
Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injuryJames W Dear, Kenneth J Simpson, Melianthe P J Nicolai, et al.
Acta Physiologica (Oxford, England)|August 3, 2024
Adipocyte endothelin B receptor activation inhibits adiponectin production and causes insulin resistance in obese miceOsvaldo Rivera-Gonzalez, Megumi F Mills, Bridget D Konadu, et al.
Iscience|January 4, 2021
Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney diseaseKathleen M Scullion, A D Bastiaan Vliegenthart, Laura Rivoli, et al.
Lancet (London, England)|September 29, 2015
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialBryan Williams, Thomas M MacDonald, Steve Morant, et al.
Nature Communications|December 5, 2023
Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatmentTariq E Farrah, Dan Pugh, Fiona A Chapman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 1, 2017
Characterization of Triptolide-Induced Hepatotoxicity by Imaging and Transcriptomics in a Novel Zebrafish ModelAdriaan D Bastiaan Vliegenthart, Chunmin Wei, Charlotte Buckley, et al.
Pageof 33

Showing results (271-280 of 323) with videos related to

Sort By:
Pageof 33
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 28, 2020
Serial troponin measurements to monitor risk and response to endothelin A antagonism in chronic kidney diseaseAtul Anand, Tariq E Farrah, Eve Miller-Hodges, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 23, 2024
Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy)Kathleen M Scullion, Iain M MacIntyre, Sian Sloan-Dennison, et al.
American Journal of Physiology. Renal Physiology|July 19, 2013
An anatomically unbiased approach for analysis of renal BOLD magnetic resonance imagesRobert I Menzies, Andrew Zammit-Mangion, Lyam M Hollis, et al.
BMJ Open|August 9, 2015
Monotherapy versus dual therapy for the initial treatment of hypertension (PATHWAY-1): a randomised double-blind controlled trialThomas M MacDonald, Bryan Williams, Mark Caulfield, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 10, 2011
Cyclophilin A is a damage-associated molecular pattern molecule that mediates acetaminophen-induced liver injuryJames W Dear, Kenneth J Simpson, Melianthe P J Nicolai, et al.
Acta Physiologica (Oxford, England)|August 3, 2024
Adipocyte endothelin B receptor activation inhibits adiponectin production and causes insulin resistance in obese miceOsvaldo Rivera-Gonzalez, Megumi F Mills, Bridget D Konadu, et al.
Iscience|January 4, 2021
Circulating argonaute-bound microRNA-126 reports vascular dysfunction and treatment response in acute and chronic kidney diseaseKathleen M Scullion, A D Bastiaan Vliegenthart, Laura Rivoli, et al.
Lancet (London, England)|September 29, 2015
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trialBryan Williams, Thomas M MacDonald, Steve Morant, et al.
Nature Communications|December 5, 2023
Choroidal and retinal thinning in chronic kidney disease independently associate with eGFR decline and are modifiable with treatmentTariq E Farrah, Dan Pugh, Fiona A Chapman, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|October 1, 2017
Characterization of Triptolide-Induced Hepatotoxicity by Imaging and Transcriptomics in a Novel Zebrafish ModelAdriaan D Bastiaan Vliegenthart, Chunmin Wei, Charlotte Buckley, et al.
Pageof 33